Monthly Alternating NALIRIFOX and GnP in the First-Line Setting for Metastatic Pancreatic Ductal Adenocarcinoma
Clinical trial NCT07163273 · RECRUITING
Trial details
- NCT number
- NCT07163273
- Sponsor
- Northwell Health
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-20
- Primary completion
- 2027-06-20
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.